Priming Of Mir-181a In Acute Myeloid Leukemia (Aml) To Increase Chemosensitivity: A Phase I Trial Of Lenalidomide (Len) Followed By Idarubicin And Cytarabine

BLOOD(2012)

引用 1|浏览20
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要